{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:06:48Z","timestamp":1789556808849,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01592-x","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:47:25Z","timestamp":1789555645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiomics-Driven Imaging Biomarkers for Predicting Chemoradiotherapy Response in Locally Advanced Rectal Cancer"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0347-2560","authenticated-orcid":false,"given":"Jawad Ali","family":"Memon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1570-7703","authenticated-orcid":false,"given":"Mohammad Sibtain","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3795-7028","authenticated-orcid":false,"given":"Zubair Ali","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1235-3311","authenticated-orcid":false,"given":"Uzma","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"1592_CR1","doi-asserted-by":"publisher","unstructured":"Altaf R, Qamar MFU, Maken RN, et al. Outcome of patients treated with neoadjuvant concurrent chemoradiation for signet ring cell rectal carcinoma. Indus J Biosci Res. 2025;3(4):943\u20137. https:\/\/doi.org\/10.70749\/ijbr.v3i4.2096","DOI":"10.70749\/ijbr.v3i4.2096"},{"key":"1592_CR2","doi-asserted-by":"publisher","unstructured":"Shen H, Jin Z, Chen Q, et al. Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis. Radiol Med. 2024;129(4):598\u2013614. https:\/\/doi.org\/10.1007\/s11547-024-01796-w","DOI":"10.1007\/s11547-024-01796-w"},{"key":"1592_CR3","doi-asserted-by":"crossref","unstructured":"He J, Wang SX, Liu P. Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: a systematic review and meta-analysis. Br J Radiol. 2024;97(1159):1243\u201354.","DOI":"10.1093\/bjr\/tqae098"},{"key":"1592_CR4","doi-asserted-by":"publisher","unstructured":"Wang Y, Pan Z, Lin L, et al. Deep learning radiomics model related with genomics phenotypes for pathological complete response prediction in locally advanced rectal cancer under neoadjuvant chemoradiotherapy. In: 2024 14th International Conference on Information Technology in Medicine and Education (ITME). IEEE; 2024. p. 689\u201397. https:\/\/doi.org\/10.1109\/ITME63426.2024.00141","DOI":"10.1109\/ITME63426.2024.00141"},{"key":"1592_CR5","doi-asserted-by":"publisher","unstructured":"Liao Z, Luo D, Tang X, et al. MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis. Front Oncol. 2025;15:1550838. https:\/\/doi.org\/10.3389\/fonc.2025.1550838","DOI":"10.3389\/fonc.2025.1550838"},{"key":"1592_CR6","doi-asserted-by":"crossref","unstructured":"Rakhsha A, Kalantari Khandani M, Shokri F. Investigating predictive factors of pathological complete response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Int J Cancer Manag. 2025;18(1):e159417.","DOI":"10.5812\/ijcm-159417"},{"key":"1592_CR7","doi-asserted-by":"publisher","unstructured":"Rai J, Mai DVC, Drami I, et al. MRI radiomics prediction modelling for pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis. Abdom Radiol. 2025;50(11):5103\u201323. https:\/\/doi.org\/10.1007\/s00261-025-04953-5","DOI":"10.1007\/s00261-025-04953-5"},{"key":"1592_CR8","doi-asserted-by":"publisher","unstructured":"Yacoub H, Zenzri Y, Cherif D, et al. Predictors of pathological complete response after total neoadjuvant treatment using short course radiotherapy for locally advanced rectal cancer. BMC Gastroenterol. 2025;25(1):208. https:\/\/doi.org\/10.1186\/s12876-025-03709-1","DOI":"10.1186\/s12876-025-03709-1"},{"key":"1592_CR9","doi-asserted-by":"publisher","unstructured":"Fan S, Wang N, Wen Y, et al. Predictive model based on mesorectal fat radiomics for pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur J Radiol. 2025;193:112378. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112421","DOI":"10.1016\/j.ejrad.2025.112421"},{"key":"1592_CR10","doi-asserted-by":"publisher","unstructured":"Yang L, Cui X, Wu F, et al. The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review. Front Immunol. 2024;15:1392499. https:\/\/doi.org\/10.3389\/fimmu.2024.1392499","DOI":"10.3389\/fimmu.2024.1392499"},{"key":"1592_CR11","doi-asserted-by":"publisher","unstructured":"Kokaine L, Gardovskis A, Gardovskis J. Evaluation and predictive factors of complete response in rectal cancer after neoadjuvant chemoradiation therapy. Medicina. 2021;57(10):1044. https:\/\/doi.org\/10.3390\/medicina57101044","DOI":"10.3390\/medicina57101044"},{"issue":"1","key":"1592_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ags3.12213","volume":"3","author":"K Yamashita","year":"2019","unstructured":"Yamashita K, Matsuda T, Hasegawa H, et al. Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: future treatment perspectives. Annals of Gastroenterological Surgery. 2019;3(1):24-33. https:\/\/doi.org\/10.1002\/ags3.12213","journal-title":"Recent Adv neoadjuvant chemoradiotherapy rectal cancer: Future Treat Perspect"},{"key":"1592_CR13","doi-asserted-by":"publisher","unstructured":"Wang Y, Shen L, Wan J, et al. Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: a new era for anal preservation. Front Immunol. 2022;13:1067036. https:\/\/doi.org\/10.3389\/fimmu.2022.1067036","DOI":"10.3389\/fimmu.2022.1067036"},{"issue":"12","key":"1592_CR14","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.3390\/cancers12123611","volume":"12","author":"F Papaccio","year":"2020","unstructured":"Papaccio F, Rosell\u00f3 S, Huerta M, et al. Neoadjuvant chemotherapy in locally advanced rectal cancer. Cancers. 2020;12(12):3611. https:\/\/doi.org\/10.3390\/cancers12123611","journal-title":"Neoadjuvant Chemother Local Adv rectal cancer"},{"key":"1592_CR15","doi-asserted-by":"publisher","unstructured":"Bourbonne V, Schick U, Pradier O, et al. Radiomics approaches for the prediction of pathological complete response after neoadjuvant treatment in locally advanced rectal cancer: ready for prime time? Cancers. 2023;15(2):432. https:\/\/doi.org\/10.3390\/cancers15020432","DOI":"10.3390\/cancers15020432"},{"key":"1592_CR16","doi-asserted-by":"publisher","unstructured":"Riley RD, Snell KIE, Ensor J, et al. Minimum sample size for developing a multivariable prediction model: part II\u2014binary and time-to-event outcomes. Stat Med. 2019;38(7):1276\u201396. https:\/\/doi.org\/10.1002\/sim.7992","DOI":"10.1002\/sim.7992"},{"key":"1592_CR17","doi-asserted-by":"publisher","unstructured":"Royston P, Moons KGM, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604. https:\/\/doi.org\/10.1136\/bmj.b604","DOI":"10.1136\/bmj.b604"},{"key":"1592_CR18","doi-asserted-by":"publisher","unstructured":"Yang L, Dong D, Fang M, et al. Can CT-based radiomics signature predict KRAS\/NRAS\/BRAF mutations in colorectal cancer? Eur Radiol. 2018;28(5):2058\u201367. https:\/\/doi.org\/10.1007\/s00330-017-5146-8","DOI":"10.1007\/s00330-017-5146-8"},{"key":"1592_CR19","doi-asserted-by":"publisher","unstructured":"Lu F, Li X, Chen X, et al. MRI-based multiregional radiomics for pretreatment prediction of pathologic complete response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: a bicenter study. Abdom Radiol. 2026;51(5):2278\u201391. https:\/\/doi.org\/10.1007\/s00261-025-05277-0","DOI":"10.1007\/s00261-025-05277-0"},{"key":"1592_CR20","doi-asserted-by":"publisher","unstructured":"Seretis F, Panagaki A, Tzamouri S, et al. Can radiomics predict pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer? A systematic review and meta-analysis of diagnostic-accuracy studies. J Pers Med. 2025;15(6):244. https:\/\/doi.org\/10.3390\/jpm15060244","DOI":"10.3390\/jpm15060244"},{"key":"1592_CR21","doi-asserted-by":"publisher","unstructured":"Li M, Dieckmann T, Herrle F, et al. Structured magnetic resonance imaging assessment improves diagnosis of pathological complete response in rectal cancer after neoadjuvant chemoradiation. Oncol Res Treat. 2026;49(4):179\u201391. https:\/\/doi.org\/10.1159\/000548042","DOI":"10.1159\/000548042"},{"issue":"11","key":"1592_CR22","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1007\/s00261-020-02502-w","volume":"45","author":"I Petkovska","year":"2020","unstructured":"Petkovska I, Tixier F, Ortiz E, et al. Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy. Abdom Radiol. 2020;45(11):3608\u201317. https:\/\/doi.org\/10.1007\/s00261-020-02502-w","journal-title":"Abdom Radiol (NY)"},{"key":"1592_CR23","doi-asserted-by":"publisher","unstructured":"Peng J, Wang W, Jin H, et al. Develop and validate a radiomics space-time model to predict the pathological complete response in patients undergoing neoadjuvant treatment of rectal cancer: an artificial intelligence model study based on machine learning. BMC Cancer. 2023;23(1):365. https:\/\/doi.org\/10.1186\/s12885-023-10855-w","DOI":"10.1186\/s12885-023-10855-w"},{"key":"1592_CR24","doi-asserted-by":"publisher","unstructured":"Defeudis A, Mazzetti S, Panic J, et al. MRI-based radiomics to predict response in locally advanced rectal cancer: comparison of manual and automatic segmentation on external validation in a multicentre study. Eur Radiol Exp. 2022;6(1):19. https:\/\/doi.org\/10.1186\/s41747-022-00272-2","DOI":"10.1186\/s41747-022-00272-2"},{"key":"1592_CR25","doi-asserted-by":"publisher","unstructured":"Li Z, Ma X, Shen F, et al. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models. BMC Med Imaging. 2021;21(1):30. https:\/\/doi.org\/10.1186\/s12880-021-00560-0","DOI":"10.1186\/s12880-021-00560-0"},{"key":"1592_CR26","doi-asserted-by":"publisher","unstructured":"Curcean S, Curcean A, Martin D, et al. The role of predictive and prognostic MRI-based biomarkers in the era of total neoadjuvant treatment in rectal cancer. Cancers (Basel). 2024;16(17):3111. https:\/\/doi.org\/10.3390\/cancers16173111","DOI":"10.3390\/cancers16173111"},{"issue":"11","key":"1592_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/jimaging8110303","volume":"8","author":"E Stamoulou","year":"2022","unstructured":"Stamoulou E, Spanakis C, Manikis G, et al. Harmonization strategies in multicenter MRI-based radiomics. J Imaging. 2022;8(11):303. https:\/\/doi.org\/10.3390\/jimaging8110303","journal-title":"J Imaging"},{"key":"1592_CR28","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1038\/s41598-022-08412-9","volume":"12","author":"H Horng","year":"2022","unstructured":"Horng H, Singh A, Yousefi B et al. Generalized ComBat harmonization methods for radiomic features with multi-modal distributions and multiple batch effects. Sci Rep 2022; 12: 4493. https:\/\/doi.org\/10.1038\/s41598-022-08412-9","journal-title":"Sci Rep"},{"key":"1592_CR29","doi-asserted-by":"publisher","unstructured":"Mali SA, Ibrahim A, Woodruff HC, et al. Making radiomics more reproducible across scanner and imaging protocol variations: a review of harmonization methods. J Pers Med. 2021;11(9):842. https:\/\/doi.org\/10.3390\/jpm11090842","DOI":"10.3390\/jpm11090842"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01592-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:47:27Z","timestamp":1789555647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01592-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1592"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01592-x","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Review Committee of Peoples University of Medical and Health Sciences for Women, Nawabshah, Pakistan (Ref: PUMHSW\/SBA\/IRB-REG\/161), the study adhered to the Declaration of Helsinki. Informed consent was obtained, ensuring confidentiality and voluntary participation.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Contribution Statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"222"}}